Amanita Muscaria Whole
Generic Name: amanita muscaria whole
Brand Names:
Agaricus Muscarius
Itching from exposure to cold*
Overview
Itching from exposure to cold*
Uses
Itching from exposure to cold*
Dosage
Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Side Effects
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen
Pregnancy
If pregnant or breast-feeding, ask a health professional before use
Frequently Asked Questions
What is Amanita Muscaria Whole used for?▼
Itching from exposure to cold*
What are the side effects of Amanita Muscaria Whole?▼
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen
Can I take Amanita Muscaria Whole during pregnancy?▼
If pregnant or breast-feeding, ask a health professional before use
Related Medications
Carboxymethylcellulose Sodium Eye Drops 0.5%
carboxymethylcellulose sodium eye drops 0.5%
Eye lubricant Eye lubricant
Alfalfa, Allium Sativum, Asparagus Officinalis, Avena Sativa, Belladonna, Berberis Vulgaris, Chelidonium Majus, Glycyrrhiza Glabra, Hydrastis Canadensis, Juniperus Virginiana, Niccolum Metallicum, Passiflora Incarnata, Sarcolacticum Acidum, Solidago Virgaurea, Taraxacum Officinale
alfalfa, allium sativum, asparagus officinalis, avena sativa, belladonna, berberis vulgaris, chelidonium majus, glycyrrhiza glabra, hydrastis canadensis, juniperus virginiana, niccolum metallicum, passiflora incarnata, sarcolacticum acidum, solidago virgaurea, taraxacum officinale
Non-Standardized Food Allergenic Extract [EPC]
Uses: For temporary relief of minor: tiredness* irritability* muscle cramps* headache* sleeplessness* restlessness* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Tirzepatide
tirzepatide
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]
11 DESCRIPTION ZEPBOUND (tirzepatide) injection, for subcutaneous use, contains tirzepatide, a GIP receptor and GLP-1 receptor agonist. Tirzepatide is based on the GIP sequence and contains aminoisobutyric acid (Aib) in positions 2 and 13, a C-terminal amide, and Lys residue at position 20 that is attached to 1,20-eicosanedioic acid via a linker. The molecular weight is 4813.53 Da and the empirical formula is C 225 H 348 N 48 O 68 .
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.